Screening for and Treating Testosterone Deficiency in Male Diabetic Patients

Tuesday, 14th May 2019 19:00 hrs (60 mins)


In this webinar, consideration will be given to the evidence for the targeted screening of hypogonadism amongst the male diabetic population and the role of testosterone replacement therapy as part of a holistic strategy in managing their hypogonadism.

  • Prevalence of TD and Diabetes
  • Physiology
  • Evidence base for treating TD in male diabetic patients
  • Manage of TD in Diabetic male patients


Dr Kam Mann

Physician in Andrology,

Men’s Health and Sexual Medicine

London, United Kingdom

Dr. Mann is an experienced Physician with a specialist interest in Andrology, Men’s Health and Sexual Medicine. He completed the Multidisciplinary Joint Committee of Sexual Medicine (MJCSM) course and Fellow of the European Committee of Sexual Medicine (FECSM). He continues to work in the NHS Andrology unit at University Hospital Southampton.

He performs assessments on patients with testosterone deficiency, erectile dysfunction, penile rehabilitation, premature ejaculation, delayed ejaculation and Men’s health and wellness.

He is a treasurer of the British Society for Sexual Medicine (BSSM), Member of the European and International Societies of Sexual Medicine (ESSM, ISSM) and, co-author of the Men’s Health Guidelines for General Practice.

Dr. Mann has been invited as a speaker and chaired scientific meetings in the field of men’s health and sexual medicine.

Professor Hugh Jones

Consultant Physician General Medicine, Diabetes and Endocrinology - Barnsley Hospital

Consultant Endocrinologist – Royal Hallamshire Hospital

Sheffield, UK

Professor Hugh Jones is a Consultant Physician in general internal medicine, diabetes and endocrinology at Barnsley Hospital. He is also an Honorary Professor of Andrology in the Department of Human Metabolism the University of Sheffield Medical School, Sheffield, UK and Hon. Consultant Endocrinologist at the Royal Hallamshire Hospital, Sheffield.

Prof. Jones is a clinical and laboratory researcher, looking into the role of testosterone in the pathogenesis and treatment of various conditions and pathologies. His major scientific discoveries are many and varied including for example determining the mechanisms of action of testosterone as an arterial vasodilator (L-channel calcium blocker).

He was elected to the European Academy of Andrology and is a co-chair of the testosterone and metabolic disorders group as part of the International Consultation on Men’ Health and Infertility to be submitted to the WHO). He is a Member of the European Association of Urology Guideline committee for Male Hypogonadism and Chair of Academic sub-committee of ABCD.

The information on this site is intended
for UK healthcare professionals only.

Are you a UK healthcare professional?

Sorry, this site is intended for
healthcare professionals only

If you have any concerns over your health,
you should speak to a medical professional.
For more information about testosterone deficiency
please visit